top of page


MAJI Moves to Cancel Over 15M Shares As It Pushes Toward Commercialization
Glioblastoma is one of medicine's most formidable enemies. It's a brain cancer so aggressive that for decades, even the most advanced...

Checkers
Sep 4, 20253 min read


Surging Volume Puts Exousia Pro (MAJI) in the Spotlight
After recording its highest trading volume in a year last Friday, now seems like a good time to pay attention to Exousia Pro ( OTC Pink...

Checkers
Mar 17, 20252 min read
bottom of page

